Loading viewer...
investor_presentation
Format: PDF investor_presentation
Bringing New Cures toLife TSHA -120 GAN Program Acquisition –Conference Call April 12 , 2021
Bringing New Cures toLife
TSHA -120 GAN Program Acquisition –Conference Call
April 12 , 2021FORWARD LOOKING STATEMENTS
This presentation contains forward -looking statements that involve substantial risks and uncertainties. All statements, other th an statements of historical facts,
contained in this presentation, including statements regarding our strategy, future operations, future financial position, fu ture revenues, projected costs,
prospects, plans and objectives of management, are forward -looking statements. The words “anticipate,” “believe,” “estimate,” “e xpect,” “intend,” “may,” “might,”
“plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar expressions areintended to identify forward -looking
statements, although not all forward -looking statements contain these identifying words. These forward -looking statements are su bject to a number of risks,
uncertainties and assumptions. Risks regarding our business are described in detail in our Securities and Exchange Commission filings, including in our Annual
Report on Form 10 -K for the year ended December 31, 2020. We may not actually achieve the plans, intentions or expectations disc losed in our forward -looking
statements, and you should not place undue reliance on our forward -looking statements. Actual results or events could differ mat erially from the plans, intentions
and expectations disclosed in the forward -looking statements we make. The forward -looking statements contained in this presentat ion reflect our current views
with respect to future events, and we assume no obligation to update any forward -looking statements except as required by applic able law.
This presentation includes statistical and other industry and market data that we obtained from industry publications and res earch, surveys and studies conducted
by third parties as well as our own estimates of potential market opportunities. All of the market data used in this prospect us involves a number of assumptions
and limitations, and you are cautioned not to give undue weight to such data. Industry publications and third -party research, su rveys and studies generally
indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the ac curacy or completeness of such
information. Our estimates of the potential market opportunities for our product candidates include several key assumptions b ased on our industry knowledge,
industry publications, third -party research and other surveys, which may be based on a small sample size and may fail to accurat ely reflect market opportunities.
While we believe that our internal assumptions are reasonable, no independent source has verified such assumptions.
2Legal disclosure3Vision
PipelineDriven by a relentless focus on discovering, developing, and
commercializing novel AAV -based gene therapies for devastating CNS disorders
Preview truncated — download the full document for the complete content.
investor_presentation
35 Pages
International Paper